Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer

SIMPLE SUMMARY: Treatment options for patients with Human Epidermal growth factor Receptor 2 positive (HER2+) metastatic breast cancer are rapidly changing, especially for patients with brain metastasis. Historically, treatment options for brain metastasis were focused on local therapies, radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: McGranahan, Tresa M., Bonm, Alipi V., Specht, Jennifer M., Venur, Vyshak, Lo, Simon S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601150/
https://www.ncbi.nlm.nih.gov/pubmed/36291922
http://dx.doi.org/10.3390/cancers14205136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601150/
https://www.ncbi.nlm.nih.gov/pubmed/36291922
http://dx.doi.org/10.3390/cancers14205136

Ejemplares similares